VOTED AS AMERICA'S TOP UROLOGISTS
A Division of WESTMED Medical Group
The Sonablate provides unprecedented hands-on control and accuracy. Due to HIFU’s level of precision that other prostate cancers do not allow, Dr. Boczko and Dr. Blair can significantly reduce the risk for side effects such as incontinence and impotence. HIFU also has a short recovery time, causes minimal blood loss or pain, and is effective in controlling cancer.
Benefits generally include the following:
The real-time imaging that is utilized by the Sonablate 500 is not available with any other device. These images are 3-dimensional, so the doctor can see the prostate clearly and monitor the process of ablation throughout the treatment. Also, because these images allow the doctor to deliver the treatment to the prostate so precisely, there is rarely damage to the surrounding tissues. These images are used along with dynamic power adjustment, allowing the doctor to change the level of power as the treatment progresses. With this ability, no patient is given too much or too little treatment. The software that comes with the device is programmed so that it can identify blood flow through the neurovascular bundles, allowing the doctor to avoid damaging these bundles.
The Sonablate® 500 is being studied in clinical trials for use in the treatment of prostate cancer in the United States and is not approved for use by the U.S. Food and Drug Administration. HIFU with the Sonablate® 500 is authorized for use for the treatment of prostate cancer in Canada, Argentina and the Dominican Republic. It is also available in the Bahamas and Mexico.
Center for Robotics, Laparoscopy, and Advanced Urology
WESTMED Medical Group
210 Westchester Avenue
Department of Urology
White Plains, NY 10604
VIEW MAP >>
1 Theall Road
171 Hugenot Street
73 Market Street-Ridge Hill
3030 Westchester Avenue
Visit WESTMED Medical 's website Group at www.westmedgroup.com